Disopyramide Phosphate
Specifications
22059-60-5CAS Number
244-756-1EC Number
4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide;phosphoric acidIUPAC Name
C21H32N3O5PChemical Formula
437.5 g/molMolecular Weight
DISOPYRAMIDE PHOSPHATE; 22059-60-5; Norpace; Rythmodan; Norpace Cr; Dirythmin sa; Diso-duriles; SC-7031 PHOSPHATE; NSC-756744; N6BOM1935W; SC-13957; CHEBI:4658; DTXSID30944685; 2-(1-(Ammoniocarbonyl)-3-(diisopropylammonio)-1-phenylpropyl)pyridinium phosphate; 4-(diisopropylamino)-2-phenyl-2-(2-pyridyl)butanamide;phosphoric acid; Dirythmin; Rythmodan ret; Dirythmin-sa; Isomide cr; RefChem:56639; Disopyramide Phosphate (1:1); DTXCID301373023; SC13957; alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide Phosphate(1:1); DISOPYRAMIDE PHOSPHATE SALT; SC 7031 phosphate; EINECS 244-756-1; SC 7031 (phosphate); 4-(diisopropylamino)-2-phenyl-2-(pyridin-2-yl)butanamide phosphate; Disopyramid phosphate; SR-01000003039; C21H32N3O5P; 22059-60-5 (phosphate); Disopyramide phosphate; (2RS)-4-[bis(1-methylethyl)amino]-2-phenyl-2-(pyridin-2-yl)butanamide dihydrogen phosphate; DisopyramidePhosphate; Norpace (TN); SC 13957; Disopyramide (phosphate); Disopyramide phosphate CRS; 4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide;phosphoric acid; UNII-N6BOM1935W; SCHEMBL41810; MLS000028431; SPECTRUM1500261; orb1705063; CHEMBL1201020; HMS501I11; CGDDQFMPGMYYQP-UHFFFAOYSA-N; Disopyramide phosphate (JAN/USP); HMS1920I14; HMS2094K15; HMS2234B16; HMS3259J21; HMS3261C04; HMS3369L05; HMS3652M20; HMS3885J07; HMS5082E20; HMS5083M09; Pharmakon1600-01500261; DISOPYRAMIDE PHOSPHATE [MI]; XAA05960; DISOPYRAMIDE PHOSPHATE [JAN]; Tox21_500411; CCG-40209; DISOPYRAMIDE PHOSPHATE [USAN]; HY-12533A; MFCD00069254; NSC756744; DISOPYRAMIDE PHOSPHATE [VANDF]; AKOS040744844; alpha-(2-Diisopropylaminoethyl)-alpha-phenyl-2-pyridineacetamide phosphate; DISOPYRAMIDE PHOSPHATE [MART.]; DISOPYRAMIDE PHOSPHATE [USP-RS]; DISOPYRAMIDE PHOSPHATE [WHO-DD]; LP00411; NC00683; NSC 756744; (+-)-alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide phosphate (1:1); 2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, phosphate; 2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, phosphate (1:1); 2-Pyridineacetamide, alpha-(2-(diisopropylamino)ethyl)-alpha-phenyl-, phosphate; alpha-(2-(Diisopropylamino)ethyl)-alpha-phenyl-2-pyridineacetamide phosphate (1:1); NCGC00093836-01; NCGC00093836-02; NCGC00093836-03; NCGC00093836-04; NCGC00261096-01; 2-Pyridineacetamide, alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-, (+-)-, phosphate (1:1); SMR000058438; DB-045779; DISOPYRAMIDE PHOSPHATE [ORANGE BOOK]; DISOPYRAMIDE PHOSPHATE [EP MONOGRAPH]; Disopyramide phosphate [USAN:USP:BAN:JAN]; EU-0100411; S4143; SW196836-3; SW196836-4; DISOPYRAMIDE PHOSPHATE [USP MONOGRAPH]; C07740; D 6035; D00637; H40410; T21424; SR-01000003039-2; SR-01000003039-6; Q27106430; 4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide,phosphoric acid; 4-DIISOPROPYLAMINO-2-PHENYL-2-(2-PYRIDYL)BUTYRAMIDE PHOSPHATE; Disopyramide phosphate, European Pharmacopoeia (EP) Reference Standard; Disopyramide phosphate, United States Pharmacopeia (USP) Reference Standard; 2-[1-(ammoniocarbonyl)-3-(diisopropylammonio)-1-phenylpropyl)]pyridinium phosphate; 4-[Di(propan-2-yl)amino]-2-phenyl-2-(pyridin-2-yl)butanimidic acid--phosphoric acid (1/1); (+/-)-.ALPHA.-(2-(DIISOPROPYLAMINO)ETHYL)-.ALPHA.-PHENYL-2-PYRIDINEACETAMIDE PHOSPHATE (1:1); 2-PYRIDINEACETAMIDE, .ALPHA.-(2-(BIS(1-METHYLETHYL)AMINO)ETHYL)-.ALPHA.-PHENYL-, (+/-)-, PHOSPHATE (1:1); 79190-73-1Synonyms
Products Containing Disopyramide Phosphate
ジソピラミド徐放錠150mg「SW」ジソピラミドリン酸塩徐放錠150mg「トーワ」ジソピラミド徐放錠150mg「VTRS」リスモダンR錠150mgRYTHMODAN 250 mg A LIBERATION PROLONGEE, comprimé enrobéISORYTHM L.P. 250 mg, gélule à libération prolongéeISORYTHM L.P. 125 mg, gélule à libération prolongéeDisopyramide - Gedeon RichterDisopyramide - PCASDisopyramide - ProcosDisopyramide - HuhtamakiDisopyramide - GD Searle LLC
Page 1 of 2